Correlation Between Cellectar Biosciences and Cynata Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cellectar Biosciences and Cynata Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cellectar Biosciences and Cynata Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cellectar Biosciences and Cynata Therapeutics Limited, you can compare the effects of market volatilities on Cellectar Biosciences and Cynata Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cellectar Biosciences with a short position of Cynata Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cellectar Biosciences and Cynata Therapeutics.

Diversification Opportunities for Cellectar Biosciences and Cynata Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Cellectar and Cynata is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cellectar Biosciences and Cynata Therapeutics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cynata Therapeutics and Cellectar Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cellectar Biosciences are associated (or correlated) with Cynata Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cynata Therapeutics has no effect on the direction of Cellectar Biosciences i.e., Cellectar Biosciences and Cynata Therapeutics go up and down completely randomly.

Pair Corralation between Cellectar Biosciences and Cynata Therapeutics

If you would invest  19.00  in Cynata Therapeutics Limited on September 13, 2024 and sell it today you would earn a total of  0.00  from holding Cynata Therapeutics Limited or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.2%
ValuesDaily Returns

Cellectar Biosciences  vs.  Cynata Therapeutics Limited

 Performance 
       Timeline  
Cellectar Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cellectar Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Cynata Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cynata Therapeutics Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Cynata Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Cellectar Biosciences and Cynata Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cellectar Biosciences and Cynata Therapeutics

The main advantage of trading using opposite Cellectar Biosciences and Cynata Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cellectar Biosciences position performs unexpectedly, Cynata Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cynata Therapeutics will offset losses from the drop in Cynata Therapeutics' long position.
The idea behind Cellectar Biosciences and Cynata Therapeutics Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios